Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171379
Status:
COMPLETED
Last Update Posted:
2011-02-02
First Post:
2005-09-12
Brief Title:
Clinical Study to Evaluate the Tolerability Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil MMF in Patients With Renal Transplant
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Open-label Study to Evaluate the Tolerability Safety and Efficacy of the Equimolar Conversion From Mycophenolate Mofetil MMF to Enteric-Coated Mycophenolate Sodium EC-MPS in Patients With Renal Transplant
Status:
COMPLETED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to evaluate the safety and efficacy of equimolar conversion from MMF to enteric-coated mycophenolate sodium in renal transplant patients receiving cyclosporine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None